In contrast, reducing KDELR1 levels increased YAP1 phosphorylation, causing YAP1 to accumulate in the cytoplasm in an inactive state, thereby suppressing cancer cell growth and improving drug sensitivity. This evidence concerns the gene YAP1 and cancer.